St Christol les Ales
+33 6 58 54 08 82

Global Awards

12

Successful projects

112

Number of staff

6 

Our Services

345

WHO ARE WE ?

CAMINNOV, a biotechnology company focused on camelid antibodies, offers state-of-the-art single domain antibody (VHH) selection and production services including animal immunisation with different antigens (Protein, peptides, toxines, chemical molecules, cell membrane, cells…), phage library synthesis, antibody fragment selection, and purification of VHHs. Additionally, we can perform engineering and functional characterizations with these antibodies.

With innovative strategies (recombinant DNA, cell biology, immunology, screening…), the CAMINNOV team has developed a platform for the production of camel single domain antibodies. We have a wide range of phage libraries obtained after immunization of lama and dromedaries with more than 400 proteins and camelid antibodies of various proteins (extracellular proteins, matrix proteins, etc).

In addition to our services activity, Caminnov has developped an internal pipeline of VHHs in many domains.
CAMINNOV have developped many VHHs, against small molecules present in the environement, and proteins playing a important role in diseases. A certain number of patents will be deposit.

CAMINNOV has won the national competition for the creation of innovative companies (Ministry of Higher Education and Research), the “Audace Ales” competition, the Commercial feasibility (LR région) and suez environnement contest. Moreover, we won the creation of innovative companies competition (IRD).

CAMINNOV, a biotechnology company focused on camelid antibodies, offers state-of-the-art VHH selection and production services including animal immunisation, phage library synthesis, screening against molecules, toxins, cells and proteins.

With innovative strategies (recombinant DNA, cell biology, immunology, screening of VHH libraries), the CAMINNOV team has developed a platform for the production of camel single domain antibodies.

CAMINNOV is developing a wide range of phage libraries and camelid antibodies of various proteins (extracellular proteins, matrix proteins, etc) and cells (Neuroblastoma, etc).

Caminnov specialized in the development of the single domain antibodies against small molecules (peptides, chemical molecules, toxins).

SCIENTIFIC BOARD




Dr. Thierry Durroux got his Ph.D. in Molecular Biology in 1991 at the University of Montpellier (France)


Dr. Thierry Durroux

Dr. Martine Cérutti, Head of the CNRS unit «Baculoviruses and Therapy» laboratory. She is a specialist in production of recombinant antibodies or proteins for therapeutic use and has made major contributions in the development of drug discovery and immunotherapy

Dr. Martine Cérutti



Dr. Jean-Philippe Pin, director of Functional Genomics Institute of Montpellier (IGF), has a long-standing expertise in GPCR and especially in
mGluR

Dr. Jean-Philippe Pin



Dr Boujaafar’s become the director of microbiology department at Sahloul University Hospital. A microbiologist specialized in antibiotics resistances domain

Dr. Noureddine Boujaafar

Global companies simply choose us because we are?

Caminnov Custom Antibody Services include many competitively priced packages and specialized purification options for antibody production. For more information and questions about :

  • Custom antibody production quotation
  • Our different protocols and guarantees
  • Discussion about yours projects
  •  Payment facility

Contact us

For administrative questions, contact our dedicated service at: [email protected]

For scientific questions, don’t hesitate to contact us by email: